Shire's DAYTRANA, first patch medication for ADHD in children, now available in pharmacies
... ... "The availability of DAYTRANA, the first and only patch for AD...Shire's DAYTRANA(TM) transdermal patch approved by FDA for treatment of ADHD
Philadelphia, PA, US and Basingstoke, UK -- Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) announced today that the U.S. Food and Drug Administration (FDA) approved DAYTRANA (methylphenidate transdermal system), the first and only non-oral medication for the treatment of attention deficit hyperactivity disorder (ADHD). DAYTRANA, a once daily transdermal patch formulation of methylphenidate, will...Shire announces positive two-year study of ADDERALL XR in the treatment of adult ADHD
Shire Announces Positive Results of Two-Year Study of ADDERALL XR in the Treatment of Adult ADHD...Data Presented at U.S. Psychiatric & Mental Health Congress... ...Las Vegas, NV November 8, 2005 A study presented today demonstrated that adults with attention-deficit/hyperactivity disorder (ADHD) experienced significant long-term ADHD symptom control when treated with once-daily ADDERALL XR (mi...